Literature DB >> 1831870

Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.

H Nagai1, K Kitagaki, S Goto, H Suda, A Koda.   

Abstract

The anti-allergic and anti-asthmatic activities of three potassium (K+) channel openers, cromakalim, pinacidil, and nicorandil, were investigated. 1) Forty-eight-hour homologous passive cutaneous anaphylaxis (PCA) in mice was not affected by cromakalim, pinacidil, or nicorandil. Ketotifen significantly inhibited the reaction. 2) Antigen-induced histamine release from sensitized guinea pig lung tissue was not affected by cromakalim, pinacidil or nicorandil (except for 10(-4) M nicorandil). Salbutamol inhibited the release of histamine. 3) Histamine, serotonin and LTC4-induced vasculitis in rat back skin was not affected by any of these three K+ channel openers. 4) Antigen-induced constriction of isolated sensitized guinea pig tracheal muscle was relaxed by each of the K+ channel openers. 5) Constrictions of isolated guinea pig tracheal muscle caused by high potassium, histamine, LTC4, or U-46619 were clearly relaxed by each of the three K+ channel openers. 6) Increases of airway resistance caused by histamine, LTD4, or U-46619 in guinea pigs in vivo were inhibited by administration of each of the three K+ channel openers. 7) Experimental asthma caused by the IgE antibody and antigen system in guinea pigs was inhibited by each of the three K+ channel openers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831870     DOI: 10.1254/jjp.56.13

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  3 in total

1.  Effects of a potassium channel opener (SDZ PCO 400) on guinea-pig and human pulmonary airways.

Authors:  I D Chapman; A Kristersson; G Mathelin; E Schaeublin; L Mazzoni; K Boubekeur; N Murphy; J Morley
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

Review 2.  Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.

Authors:  J Frampton; M M Buckley; A Fitton
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

3.  Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma.

Authors:  N S Cook; I D Chapman
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.